Ambitious efforts to make the EU more resilient to future challenges, such as health threats, drug supply problems, scientific advances and growing medicine costs, have taken a step forward with the publication of a roadmap for a wide-ranging Pharmaceutical Strategy to be adopted by the European Commission later in the year.
The European Commission has unveiled a set of proposals for overhauling the EU drug regulatory framework in order to ensure timely patient access to affordable medicines, support the development of innovative medicines that meet patients’ needs, and tackle the root causes of drug shortages.
In a “